What Screening and Confirmation Cutoffs Mean? In Drug Testing

Two threshold concentrations, measured in nanograms per milliliter, govern every step of a modern workplace drug test from initial screen to final result. A screening cutoff is the lower bar an initial immunoassay must clear to flag a specimen as presumptive positive, while a confirmation cutoff is the stricter bar a GC-MS or LC-MS/MS instrument must clear before a lab reports a real positive.

Together, these two numbers form the legal and scientific backbone that makes employment-related drug testing defensible in court.

This guide walks through how screening and confirmation cutoffs work in workplace drug testing, covering the regulatory framework behind them, typical values across standard panels, and how those thresholds shape contested results.

The Two Thresholds Behind Every Workplace Drug Test

A single urine specimen typically moves through two instrument queues before a result is reported. The first queue is a high-volume immunoassay analyzer such as EMIT, ELISA, or CEDIA, built to push through hundreds of specimens an hour. The second queue is a slower, far more discriminating mass spectrometer capable of distinguishing one molecule from its chemical twins. Each instrument carries its own threshold concentration, and the gap between those two thresholds is where most workplace confusion lives.

A screening cutoff is the concentration an initial test must detect before the lab treats a specimen as presumptive positive. A confirmation cutoff is the higher concentration the second method must verify before the same specimen becomes a reported positive. The confirmation step exists because immunoassays cross-react with substances that look chemically similar to the target drug, so a second look is non-negotiable when employment, licensure, or legal consequences hang in the balance.

The relationship between the two cutoffs is a deliberate sensitivity-versus-specificity trade-off, not a pair of numbers picked from a hat. The screening threshold leans toward sensitivity, casting a wide net to catch nearly every true user. The confirmation threshold leans toward specificity, requiring rock-solid analytical proof before a person is labeled positive. That design choice is what separates a defensible testing program from a coin flip.

Why Screening Cutoffs Run Lower Than Confirmation Cutoffs

Setting a single cutoff on a single instrument and letting that number decide a career carries brutal risk in both directions. A false positive can cost someone a job offer or a promotion they earned. A false negative lets an impaired worker keep operating heavy machinery or treating patients. Splitting the decision into two thresholds is how the testing industry manages that risk.

Sensitivity First, Specificity Second

The screening cutoff sits low on purpose so the immunoassay catches nearly every true user. If a lab missed half the positives in a workplace pool, the program would lose its deterrent value overnight and the company would face real safety exposure. Catching everything that could possibly be a positive is the entire job of the initial test, even when that means the lab has to chase a few false alarms afterward.

The confirmation cutoff then runs higher because mass spectrometry gives the lab something immunoassays cannot: near-absolute chemical certainty. GC-MS separates compounds by their interaction with a gas chromatography column and then smashes each one into a fingerprint of molecular fragments. LC-MS/MS does the same job with liquid chromatography and two stages of mass filtering. Either method can distinguish tetrahydrocannabinol from a closely related cannabinoid that an antibody would happily flag by mistake.

What the Two-Tier System Means in Practice

A negative screen is final. No further work runs, the result is reported, and the specimen can be discarded after the chain-of-custody window closes. A presumptive positive, by contrast, must survive the confirmation step before anyone with hiring authority ever sees it. In practical terms, the initial test is a filter and the confirmation is the verdict.

An MRO (Medical Review Officer) cannot legally report a positive result based on screening alone. Any program that reports screen-only positives violates federal workplace testing standards and creates immediate legal exposure. The two-tier design is the only practical way to balance catching users with protecting the innocent.

Those legal stakes are exactly why SAMHSA’s framework and GC-MS confirmation became the backbone of federal testing standards.

“Tip: When reviewing a lab report, always check whether the printed value is labeled as a screening result or a confirmation result. The number alone is meaningless without the stage attached.

SAMHSA, GC-MS, and the Regulatory Framework That Defines the Numbers

Federal workplace drug testing runs on a set of mandatory cutoff tables published by the Substance Abuse and Mental Health Services Administration (SAMHSA). These tables cover programs regulated by the Department of Transportation (DOT) and any agency that follows federal employee-testing rules. Private employers are not legally required to use SAMHSA’s numbers, but the vast majority adopt them by reference because doing so gives their program an instant presumption of scientific and legal validity.

Who Sets the Standard Cutoffs

SAMHSA’s cutoff tables specify both the screening and confirmation threshold for every analyte in the standard panel, expressed in ng/mL and adapted to the specimen matrix. The most common panel is the NIDA-5, also called the SAMHSA-5, which covers marijuana, cocaine, amphetamines, opioids, and PCP. Labs running federal samples must use the exact numbers published in the Federal Register and must also participate in proficiency testing administered through agencies like the HHS-certified National Laboratory Certification Program.

State laws and individual employer policies can tighten these thresholds, but they cannot relax them below federal floors where DOT-regulated work is involved. Some sectors, including nuclear and certain federal safety-sensitive positions, run cutoffs at or below SAMHSA’s published numbers to catch lower-level use.

Why Each Matrix Carries Its Own Threshold

Cutoff units stay consistent across most workplace testing (ng/mL), but the actual concentration in urine, oral fluid, or hair reflects very different pharmacokinetics. Urine carries metabolites hours to days after use, oral fluid captures very recent exposure, and hair grows out a roughly 90-day record in roughly 1-centimeter segments. Each matrix therefore has its own SAMHSA-published cutoff values because the same absolute concentration means different things in different specimens.

A program that switches matrices without adjusting cutoffs is effectively using the wrong yardstick.

Typical Cutoff Values Across the Standard Drug Panels

The numbers below reflect the most commonly cited SAMHSA-aligned thresholds for urine, the matrix used in the majority of workplace tests. They are reference points, not legal minimums, and they shift as the agency revises its tables.

Several nuances are worth flagging. THC’s confirmation cutoff of 15 ng/mL sits lower than its 50 ng/mL screening cutoff in the most commonly cited urine framework, a deliberate choice that lets the immunoassay’s wider net catch borderline samples while the more specific GC-MS confirms or clears them. Codeine and morphine each carry separate confirmation thresholds, and expanded opioid panels now include thresholds for oxycodone, hydromorphone, hydrocodone, and 6-acetylmorphine, the last being a heroin-specific marker.

Cutoffs are also analyte-specific, meaning a single drug class can carry several different numbers. Amphetamine and methamphetamine, for example, have their own confirmation thresholds even though they share one screening cutoff. This split lets labs identify which specific compound was present rather than collapsing everything into a generic class hit.

Those same split thresholds are what drive the false positive and false negative rates employers actually see on paper.

How Cutoffs Shape False Positives, False Negatives, and Contested Results

Every cutoff is a judgment call about which type of error a program can tolerate. Push the screening bar too low and the lab starts chasing poppy seed bagels, ibuprofen, and certain antidepressants that share structural features with drugs of abuse. Push any cutoff too high and genuine users sail through the program undetected, eroding the deterrent value the test was meant to create.

The Cost of Cutoffs Set Too Low

Immunoassays rely on antibodies that can be fooled by cross-reactive molecules. Poppy seeds contain enough morphine and codeine to trip a low screening cutoff for opioids, which is why SAMHSA raised the opioid screening threshold to 2000 ng/mL years ago. NSAIDs like ibuprofen and naproxen have historically triggered false amphetamine signals on certain immunoassay platforms, and certain supplements marketed as sleep aids or pre-workout boosters have produced false positives for stimulants.

Every one of those false alarms gets caught at confirmation, which is precisely why the second step exists.

The Cost of Cutoffs Set Too High

Raise the bar and a different problem appears. A heavy user who abstains for two days before a test, or someone with a fast metabolism, can fall below even a generous threshold. Programs that rely on cutoffs alone without considering detection windows in their chosen matrix lose both accuracy and credibility when positive users keep passing.

The Gray Zone: When the Two Tests Disagree

A specimen that clears the screening cutoff but fails the confirmation cutoff lands in the gray zone and is reported as negative. From the program’s perspective, the positive screen was a false positive caused by antibody cross-reactivity. From the donor’s perspective, the system worked exactly as designed.

The gray zone is uncomfortable for HR teams because it produces visible near misses on internal reports, but it is the unavoidable cost of running a sensitive screening test in the first place.

Seeing those near misses in the data is precisely when a clear reading method for lab reports starts earning its keep.

Reading a Lab Report and Choosing the Right Threshold for Your Program

An MRO report looks intimidating at first glance, but the layout is standardized and every column has a purpose. The left side identifies the specimen and the chain-of-custody seal number. The middle columns list each analyte in the panel alongside its screening cutoff, the screening result, the confirmation cutoff, and the confirmation result. Anything flagged POS at the confirmation stage is the only result that legally counts.

How to Read a Medical Review Officer Report

Start by locating the analyte of interest, then read across the row. The screening column shows whether the immunoassay detected the analyte above its cutoff. The confirmation column shows the final concentration measured by GC-MS or LC-MS/MS and whether it cleared the confirmation cutoff.

The MRO’s signature block indicates whether the result was verified, whether the donor was contacted for a legitimate medical explanation, and whether the final reported outcome is positive, negative, or rejected for a procedural reason such as a broken seal or an out-of-temperature specimen.

Best Practices for HR and Compliance Teams

• ▸Adopt SAMHSA cutoffs by reference. Writing “program follows current SAMHSA mandatory guidelines” into your policy keeps your numbers current without constant rewrites.
• ▸Document chain of custody. Every specimen should travel from collection to MRO with an unbroken, signed paper trail that a courtroom can follow.
• ▸Train managers to talk in cutoff terms. A supervisor who can explain that a negative screen is final and a positive screen must be confirmed defuses more disputes than any legal memo.
• ▸Choose your matrix deliberately. Urine is the default, oral fluid detects more recent use, and hair extends the detection window back months. Pick the matrix that matches the safety risk you are trying to manage.
• ▸Track gray-zone results. Frequent near misses at confirmation can reveal a screening cutoff set too low or an immunoassay platform prone to cross-reactivity.
• ▸Audit your MRO contract. Confirm that the MRO is a licensed physician independent of the laboratory and that the MRO has authority to verify legitimate prescriptions before reporting a positive.

The Editor’s Takeaway

The two-tier threshold system is not a bureaucratic technicality. It is the legal and scientific foundation that makes workplace drug testing defensible, repeatable, and fair. Once the reason for the screening cutoff sitting lower than the confirmation cutoff becomes clear, the rest of the testing process clicks into place, and the printed numbers on a lab report stop looking like a foreign language.

The Big Picture

Cutoffs are the quiet architecture behind every defensible drug test. Screening thresholds cast a wide net on purpose, confirmation thresholds narrow it back down with chemical precision, and SAMHSA’s published tables keep both numbers anchored in science rather than guesswork. Once the gap between the two is understood, any lab report becomes readable, matrix-appropriate thresholds can be chosen for an individual program, and the system can be explained to anyone who asks, from a new hire to an attorney.

FAQ